Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case.
Cushing disease
PitNET
pituitary adenoma
pituitary neuroendocrine tumor
prolactinoma
transsphenoidal
Journal
Journal of neurosurgery. Case lessons
ISSN: 2694-1902
Titre abrégé: J Neurosurg Case Lessons
Pays: United States
ID NLM: 9918227275606676
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
31
08
2023
accepted:
28
09
2023
medline:
27
11
2023
pubmed:
27
11
2023
entrez:
27
11
2023
Statut:
epublish
Résumé
Double pituitary adenomas are rare presentations of two distinct adenohypophyseal lesions seen in <1% of surgical cases. Increased rates of recurrence or persistence are reported in the resection of Cushing microadenomas and are attributed to the small tumor size and localization difficulties. The authors report a case of surgical treatment failure of Cushing disease because of the presence of a secondary pituitary adenoma. A 32-year-old woman with a history of prolactin excess and pituitary lesion presented with oligomenorrhea, weight gain, facial fullness, and hirsutism. Urinary and nighttime salivary cortisol elevation were elevated. Magnetic resonance imaging confirmed a 4-mm3 pituitary lesion. Inferior petrosal sinus sampling was diagnostic for Cushing disease. Primary endoscopic endonasal transsphenoidal resection was performed to remove what was determined to be a lactotroph-secreting tumor on immunohistochemistry with persistent hypercortisolism. Repeat resection yielded a corticotroph-secreting tumor and postoperative hypoadrenalism followed by long-term normalization of the hypothalamic-pituitary-adrenal axis. This case demonstrates the importance of multidisciplinary management and postoperative hormonal follow-up in patients with Cushing disease. Improved strategies for localization of the active tumor in double pituitary adenomas are essential for primary surgical success and resolution of endocrinopathies.
Sections du résumé
BACKGROUND
BACKGROUND
Double pituitary adenomas are rare presentations of two distinct adenohypophyseal lesions seen in <1% of surgical cases. Increased rates of recurrence or persistence are reported in the resection of Cushing microadenomas and are attributed to the small tumor size and localization difficulties. The authors report a case of surgical treatment failure of Cushing disease because of the presence of a secondary pituitary adenoma.
OBSERVATIONS
METHODS
A 32-year-old woman with a history of prolactin excess and pituitary lesion presented with oligomenorrhea, weight gain, facial fullness, and hirsutism. Urinary and nighttime salivary cortisol elevation were elevated. Magnetic resonance imaging confirmed a 4-mm3 pituitary lesion. Inferior petrosal sinus sampling was diagnostic for Cushing disease. Primary endoscopic endonasal transsphenoidal resection was performed to remove what was determined to be a lactotroph-secreting tumor on immunohistochemistry with persistent hypercortisolism. Repeat resection yielded a corticotroph-secreting tumor and postoperative hypoadrenalism followed by long-term normalization of the hypothalamic-pituitary-adrenal axis.
LESSONS
CONCLUSIONS
This case demonstrates the importance of multidisciplinary management and postoperative hormonal follow-up in patients with Cushing disease. Improved strategies for localization of the active tumor in double pituitary adenomas are essential for primary surgical success and resolution of endocrinopathies.
Identifiants
pubmed: 38011690
doi: 10.3171/CASE23485
pii: CASE23485
pmc: PMC10684060
doi:
pii:
Types de publication
Journal Article
Langues
eng
Références
Front Endocrinol (Lausanne). 2016 Feb 01;7:1
pubmed: 26869991
Endocr Pathol. 2018 Dec;29(4):332-338
pubmed: 30215160
J Neurosurg. 1991 Feb;74(2):243-7
pubmed: 1988594
J Neurosurg. 2018 Apr;128(4):1051-1057
pubmed: 28452619
Endocr Pathol. 2022 Mar;33(1):6-26
pubmed: 35291028
J Endocrinol Invest. 2010 May;33(5):325-31
pubmed: 19955848
World Neurosurg. 2019 Jun;126:331-335
pubmed: 30898745
Clin Endocrinol (Oxf). 2004 Jul;61(1):26-30
pubmed: 15212641
Mod Pathol. 2018 Jun;31(6):900-909
pubmed: 29434339
AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1183-90
pubmed: 8237701
Ann Intern Med. 1978 Sep;89(3):345-8
pubmed: 686546
Pituitary. 2016 Oct;19(5):472-81
pubmed: 27209585
Pituitary. 2022 Aug;25(4):587-601
pubmed: 35616762
Clin Endocrinol (Oxf). 1993 Sep;39(3):307-13
pubmed: 8222293
J Neurosurg. 2000 Nov;93(5):753-61
pubmed: 11059654
Pituitary. 2020 Oct;23(5):595-609
pubmed: 32691356
J Neurosurg. 2018 Sep;129(3):629-641
pubmed: 29027854
J Clin Endocrinol Metab. 1998 Jul;83(7):2291-5
pubmed: 9661597
Clin Chem. 1994 Jul;40(7 Pt 1):1344
pubmed: 8013111
Pituitary. 2019 Dec;22(6):620-632
pubmed: 31598814
Endocr Pathol. 2010 Jun;21(2):135-8
pubmed: 20058099
Endocr Pathol. 2023 Sep;34(3):273-278
pubmed: 37268858